title: Physicians' awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis.
abstract: BACKGROUND
  Recent trials have shown that cytoreductive surgery and heated intraperitoneal chemotherapy (S+HIPEC) for colorectal cancer carcinomatosis (CRC-C) leads to 5-year, disease-free survival rates of more than 30%. Since these data represent a substantial change in the management of CRC-C, the objectives of this study were to determine physicians' awareness of S+HIPEC for CRC-C and physician characteristics predictive of awareness of S+HIPEC for CRC-C.
  
  
  METHODS
  This study was a mailed, cross-sectional survey of general surgeons and medical oncologists in Ontario.
  
  
  RESULTS
  The response rate was 44.0% (214 of 487). Most respondents were men and younger than 50 years. There was an even split between those at academic and community hospitals. Overall, 46% of respondents were aware of S+HIPEC for CRC-C, and multivariate analysis showed that there were no physician characteristics predictive of awareness of S+HIPEC for CRC-C.
  
  
  CONCLUSIONS
  Physician awareness of S+HIPEC for CRC-C is low. Therefore, strategies to improve patient and physician knowledge about S+HIPEC for CRC-C are important to ensure appropriate treatment for patients.
authors.affiliation: Department of Medicine, University of Toronto, Toronto, Ont.
authors.forename: Gillian
authors.initials: G
authors.lastname: Spiegle
authors.forename: Selina
authors.initials: S
authors.lastname: Schmocker
authors.forename: Harden
authors.initials: H
authors.lastname: Huang
authors.forename: J Charles
authors.initials: JC
authors.lastname: Victor
authors.forename: Calvin
authors.initials: C
authors.lastname: Law
authors.forename: J Andrea
authors.initials: JA
authors.lastname: McCart
authors.forename: Erin Diane
authors.initials: ED
authors.lastname: Kennedy
mesh_terms: D000046:Academic Medical Centers; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion; D002983:Clinical Competence; D015179:Colorectal Neoplasms / Q000473:pathology; D003430:Cross-Sectional Studies; D005260:Female; D013502:General Surgery; D006764:Hospitals, Community; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008495:Medical Oncology; D008875:Middle Aged; D015999:Multivariate Analysis; D009864:Ontario; D057240:Patient Preference; D010534:Peritoneal Neoplasms / Q000628:therapy*; D011553:Pseudomyxoma Peritonei / Q000628:therapy*; D012017:Referral and Consultation; D011795:Surveys and Questionnaires; D014850:Waiting Lists